TotalMarketCap

RxSight

RXSTNasdaq United StatesHealth CareOphthalmic Goods

Market cap

$189.730 M

$4.53 -9.32%

Close of 6 Nov 2026

As of 6 Nov 2026, RxSight (RXST) has a market capitalization of $189.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$134.5M

#2401 by revenue

Earnings

-$38.90

Loss-making

Shares outstanding

41,929,222

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Ophthalmic Goods, ranked by market cap

All 8 →
  1. #4Warby ParkerWRBY$3.22B
  2. #5National VisionEYE$1.41B
  3. #6Staar SurgicalSTAA$1.34B
  4. #7RxSightRXST$189.7M
  5. #8Innovative EyewearLUCY$7.22M

What if RxSight were worth as much as…

Open the what-if tool →

Gold $28.2T

$673,441.40

Per share 148,827× higher

Bitcoin $1.53T

$36,438.74

Per share 8,053× higher

Apple $5.02T

$119,624.99

Per share 26,436× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for RxSight are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.